Table 3.
Population Characteristics According to AF-Related Hospitalization
| No Hospitalization (n = 1,577) | AF-Related Hospitalization (n = 180) | P Value | |
|---|---|---|---|
| Women | 43.9 | 42.8 | 0.812 |
| Age, y | 74.7 ± 9.4 | 71.5 ± 8.5 | <0.001 |
| Permanent/persistent AF | 62.8 | 53.3 | 0.014 |
| Arterial hypertension | 85.5 | 88.9 | 0.210 |
| Diabetes | 19.6 | 17.2 | 0.455 |
| Previous stroke/TIA | 14.7 | 12.8 | 0.509 |
| Previous myocardial infarction | 15.5 | 11.7 | 0.167 |
| COPD | 12.5 | 13.3 | 0.785 |
| Cancer | 12.8 | 18.9 | 0.024 |
| Heart failure | 12.6 | 11.1 | 0.568 |
| CKD | 31.5 | 31.1 | 0.893 |
| CHA2DS2-VASc | 3.5 ± 1.5 | 3.2 ± 1.6 | 0.013 |
| HAS-BLED | 2.2 ± 0.8 | 2.2 ± 0.9 | 0.932 |
| Therapy | |||
| DOAC | 39.1 | 16.7 | <0.001 |
| Lipid-lowering therapy | 38.2 | 45.0 | 0.073 |
| ACEI/ARBs | 59.8 | 68.3 | 0.027 |
| Beta-blockers | 45.3 | 42.8 | 0.493 |
| Calcium-channel blockers | 26.1 | 27.2 | 0.727 |
| Verapamil/diltiazem | 9.5 | 13.3 | 0.101 |
| Nitrates | 7.9 | 8.3 | 0.876 |
| Antiarrhythmics | 25.8 | 43.9 | <0.001 |
| Class Ic | 12.9 | 22.8 | <0.001 |
| Amiodarone | 13.4 | 22.2 | <0.001 |
| Digoxin | 12.5 | 12.2 | 0.915 |
| Hypoglycemic drugs | 15.2 | 15.0 | 0.951 |
| Diuretics | 42.7 | 39.4 | 0.403 |
| Proton pump inhibitor | 45.8 | 45.0 | 0.844 |
Values are % or mean ± SD.
Abbreviations as in Table 1.